The GLP-1 Analogue Liraglutide Protects Cardiomyocytes from High Glucose-induced Apoptosis by Activating the Epac-1/Akt Pathway

  • X.-M. Wu, Q.-Y. Ou, W. Zhao, J. Liu, H. Zhang
  • Experimental and Clinical Endocrinology & Diabetes, August 2014, Thieme Publishing Group
  • DOI: 10.1055/s-0034-1384584

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Ming Xiao WU